Peptidyl-methionine modification

pathway activity — cross-omics
GO:0018206Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-methionine modification pathway is significantly associated with the RNA expression of multiple genes, with the UCEC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MAMDC2, MAOB, and LIFR, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-methionine modification activity versus MAMDC2 in UCEC (Pearson r = 0.17).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECMAMDC2 →-0.992-0.139.005.00234
BRCAMAOB →-1.580-0.129<.001.00934
UCECLIFR →-0.859-0.134.001.00733
OVANKRD42 →-0.499-0.113<.001.00333
OVTXNDC11 →-0.418-0.140.003.00233
OVCHKB-DT →-0.403-0.120.009.00433
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018206 vs MAMDC2 — UCEC

Per-sample scatter of Peptidyl-methionine modification activity vs MAMDC2 in UCEC.

Explore this scatter interactively →

Exploration